Mechanisms of HIV-1 integrase resistance to dolutegravir and potent inhibition of drug-resistant variants

Author:

Li Min1ORCID,Oliveira Passos Dario2ORCID,Shan Zelin2ORCID,Smith Steven J.3ORCID,Sun Qinfang4ORCID,Biswas Avik25ORCID,Choudhuri Indrani4ORCID,Strutzenberg Timothy S.2ORCID,Haldane Allan5ORCID,Deng Nanjie6ORCID,Li Zhaoyang1,Zhao Xue Zhi3ORCID,Briganti Lorenzo7ORCID,Kvaratskhelia Mamuka7ORCID,Burke Terrence R.3ORCID,Levy Ronald M.5ORCID,Hughes Stephen H.3ORCID,Craigie Robert1ORCID,Lyumkis Dmitry289ORCID

Affiliation:

1. National Institute of Diabetes and Digestive Diseases, National Institutes of Health, Bethesda, MD, 20892, USA.

2. The Salk Institute for Biological Studies, La Jolla, CA, 92037, USA.

3. Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD, 21702, USA.

4. Center for Biophysics and Computational Biology, and Department of Chemistry, Temple University, Philadelphia, PA 19122, USA.

5. Center for Biophysics and Computational Biology and Department of Physics, Temple University, Philadelphia, PA 19122, USA.

6. Department of Chemistry and Physical Sciences, Pace University, New York, NY, 10038, USA.

7. Division of Infectious Diseases, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.

8. Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, 92037, USA.

9. Graduate School of Biological Sciences, Section of Molecular Biology, University of California San Diego, La Jolla, CA 92093, USA.

Abstract

HIV-1 infection depends on the integration of viral DNA into host chromatin. Integration is mediated by the viral enzyme integrase and is blocked by integrase strand transfer inhibitors (INSTIs), first-line antiretroviral therapeutics widely used in the clinic. Resistance to even the best INSTIs is a problem, and the mechanisms of resistance are poorly understood. Here, we analyze combinations of the mutations E138K, G140A/S, and Q148H/K/R, which confer resistance to INSTIs. The investigational drug 4d more effectively inhibited the mutants compared with the approved drug Dolutegravir (DTG). We present 11 new cryo-EM structures of drug-resistant HIV-1 intasomes bound to DTG or 4d, with better than 3-Å resolution. These structures, complemented with free energy simulations, virology, and enzymology, explain the mechanisms of DTG resistance involving E138K + G140A/S + Q148H/K/R and show why 4d maintains potency better than DTG. These data establish a foundation for further development of INSTIs that potently inhibit resistant forms in integrase.

Publisher

American Association for the Advancement of Science (AAAS)

Subject

Multidisciplinary

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3